Could an ancient chinese formula save lives in leukemia?
NCT ID NCT07503730
First seen Apr 01, 2026 · Last updated May 25, 2026 · Updated 11 times
Summary
This study tests if giving a special Chinese medicine formula (RIF) along with standard treatment right away can lower the risk of early death in people with a fast-growing blood cancer called acute promyelocytic leukemia (APL). About 224 adults with suspected APL will be split into two groups: one gets the standard drug plus RIF, the other gets standard treatment alone. The goal is to see if the early combo helps prevent dangerous bleeding and improves survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Affiliated Hospital of Xi'an Jiaotong University
RECRUITINGXi'an, Shaanxi, 710061, China
Conditions
Explore the condition pages connected to this study.